Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
5.41
+0.28 (5.46%)
At close: Mar 9, 2026, 4:00 PM EDT
5.40
-0.01 (-0.18%)
After-hours: Mar 9, 2026, 4:25 PM EDT
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $2.23 billion as of March 9, 2026. Its market cap has increased by 30.35% in one year.
Market Cap
2.23B
Enterprise Value
1.97B
1-Year Change
30.35%
Ranking
Category
Stock Price
$5.41
Market Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $2.23B, an increase of 811.17%. That is a compound annual growth rate of 22.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.11B | 95.02% |
| Dec 31, 2025 | 1.08B | -51.95% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
| Feb 26, 2015 | 244.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocular Therapeutix | 2.24B |
| Day One Biopharmaceuticals | 2.19B |
| Zai Lab | 2.19B |
| Maze Therapeutics | 2.16B |
| Galapagos NV | 2.15B |
| Ascentage Pharma Group International | 2.13B |
| Mineralys Therapeutics | 2.10B |
| Mesoblast | 2.08B |